|
LY-2090314 |
|
CHEBI:167661 |
|
A member of the class of diazepinoindoles that is 1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indole substituted by piperidin-1-ylcarbonyl, 4-(imidazo[1,2-a]pyridin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl and fluoro groups at position 2, 7 and 9, respectively. It is a potent ATP-competitive inhibitor of glycogen synthase kinase-3 (GSK-3) with IC50 values of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β. The drug is in clinical development for the treatment of advanced/metastatic cancer. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
R. Stephan
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37) |
HRJWTAWVFDCTGO-UHFFFAOYSA-N |
FC1=CC2=C3N(CCN(C2)C(=O)N2CCCCC2)C=C(C3=C1)C1=C(C(=O)NC1=O)C1=CN=C2C=CC=CN12 |
|
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Wnt signalling activator
A substance that activates any of the Wnt signalling pathway, a group of signal transduction pathways made of proteins that pass signals from outside of a cell through cell surface receptors to the inside of the cell.
EC 2.7.11.26 (tau-protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of tau-protein kinase inhibitor (EC 2.7.11.26).
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
3-[9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
|
3-[9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepin-7-yl]-4-imidazo[1,2-a]pyridin-3-yl-1H-pyrrole-2,5-dione
|
ChEBI
|
LY 2090314
|
ChemIDplus
|
LY2090314
|
ChEBI
|
603288-22-8
|
CAS Registry Number
|
ChemIDplus
|
15267232
|
PubMed citation
|
SUBMITTER
|
23305709
|
PubMed citation
|
Europe PMC
|
24658455
|
PubMed citation
|
Europe PMC
|
25915038
|
PubMed citation
|
Europe PMC
|
26403509
|
PubMed citation
|
Europe PMC
|
26735141
|
PubMed citation
|
SUBMITTER
|
26967552
|
PubMed citation
|
Europe PMC
|
28397338
|
PubMed citation
|
Europe PMC
|
28766886
|
PubMed citation
|
Europe PMC
|
28772167
|
PubMed citation
|
Europe PMC
|
29593255
|
PubMed citation
|
Europe PMC
|
29751783
|
PubMed citation
|
Europe PMC
|
31261037
|
PubMed citation
|
Europe PMC
|
31562256
|
PubMed citation
|
Europe PMC
|
31623866
|
PubMed citation
|
Europe PMC
|
32382110
|
PubMed citation
|
Europe PMC
|
32391602
|
PubMed citation
|
Europe PMC
|
32539133
|
PubMed citation
|
Europe PMC
|
|